Lv11
40 积分 2023-04-09 加入
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease
2小时前
待确认
Endoscopic scores for inflammatory bowel disease in the era of ‘mucosal healing’: Old problem, new perspectives
2个月前
已完结
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
2个月前
已完结
Dietary factors and patterns in relation to risk of later‐onset ulcerative colitis in Chinese: A prospective study of 0.5 million people
2个月前
已完结
Editorial: Exploring the influence of diet on later‐onset ulcerative colitis—Are eggs and spicy foods the key factors in Asia?
2个月前
已关闭
Liver dysfunction in inflammatory bowel disease
4个月前
已完结
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
5个月前
已完结
European consensus on the histopathology of inflammatory bowel disease
9个月前
已完结
Sex-Dimorphic Analyses Identify Novel and Sex-Specific Genetic Associations in Inflammatory Bowel Disease
9个月前
已完结
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study
10个月前
已完结
皖公网安备34019202002308
